Icariin Improves Memory Impairment in Alzheimer's Disease Model Mice (5xFAD) and Attenuates Amyloid β-induced Neurite Atrophy

被引:147
作者
Urano, Takuya [1 ,2 ]
Tohda, Chihiro [1 ]
机构
[1] Toyama Univ, Div Biofunct Evaluat, Res Ctr Ethnomed, Inst Nat Med, Toyama 9300194, Japan
[2] Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 9300194, Japan
关键词
icariin; Epimedii Herba; Alzheimer's disease; neurite atrophy; 5xFAD; spatial memory; PROTOPANAXADIOL-TYPE SAPONINS; EMBRYONIC STEM-CELLS; NEURON LOSS; TRANSGENIC MICE; MOUSE MODELS; NEURODEGENERATION; ACCUMULATION; MUTATIONS; PLAQUES; PROTEIN;
D O I
10.1002/ptr.3183
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
Essential therapeutic drugs for Alzheimer's disease (AD) have not been developed. Since the neuritic atrophy leading to synaptic losses is one of the critical causes of memory impairment in AD, the effects of several constituents in tonic herbal medicines on neuritic atrophy and memory deficits have been studied. The present study investigated the effects of icariin, a main constituent in Epimedii Herba, a well known tonic crude drug, in an in vitro AD model and transgenic mouse AD model (5xFAD). Amyloid beta(1-42)-induced atrophies of axons and dendrites were restored by post-treatment with icariin in rat cortical neurons. Administration of icariin for 8 days (p.o.) improved spatial memory impairment in 5xFAD mice. These novel findings suggest that icariin may improve memory dysfunction in AD and have a potential to extend neurites even when amyloid beta-induced neurite atrophy has already occurred. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:1658 / 1663
页数:6
相关论文
共 36 条
[1]
Synaptic degeneration in Alzheimer's disease [J].
Arendt, Thomas .
ACTA NEUROPATHOLOGICA, 2009, 118 (01) :167-179
[2]
Impairments in learning and memory accompanied by neurodegeneration in mice transgenic for the carboxyl-terminus of the amyloid precursor protein [J].
Berger-Sweeney, J ;
McPhie, DL ;
Arters, JA ;
Greenan, J ;
Oster-Granite, ML ;
Neve, RL .
MOLECULAR BRAIN RESEARCH, 1999, 66 (1-2) :150-162
[3]
Neuronal death versus synaptic pathology in Alzheimer's disease [J].
Bertoni-Freddari, C ;
Fattoretti, P ;
Solazzi, M ;
Giorgetti, B ;
Di Stefano, G ;
Casolia, T ;
Meier-Ruge, W .
APOPTOSIS: FROM SIGNALING PATHWAYS TO THERAPEUTIC TOOLS, 2003, 1010 :635-638
[4]
Massive CA1/2 neuronal loss with intraneuronal and N-interminal truncated Aβ42 accumulation in a novel Alzheimer transgenic model [J].
Casas, C ;
Sergeant, N ;
Itier, JM ;
Blanchard, V ;
Wirths, O ;
van der Kolk, N ;
Vingtdeux, V ;
van de Steeg, E ;
Ret, G ;
Canton, T ;
Drobecq, H ;
Clark, A ;
Bonici, B ;
Delacourte, A ;
Benavides, J ;
Schmitz, C ;
Tremp, G ;
Bayer, TA ;
Benoit, P ;
Pradier, L .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (04) :1289-1300
[5]
The morphological phenotype of β-amyloid plaques and associated neuritic changes in Alzheimer's disease [J].
Dickson, TC ;
Vickers, JC .
NEUROSCIENCE, 2001, 105 (01) :99-107
[6]
Ding L, 2008, STEM CELLS DEV, V17, P751, DOI [10.1089/scd.2008.0206, 10.1089/scd.2007.0206]
[7]
Intracellular A-beta amyloid, a sign for worse things to come? [J].
Echeverria, V ;
Cuello, AC .
MOLECULAR NEUROBIOLOGY, 2002, 26 (2-3) :299-316
[8]
Aβ1-42 reduces synapse number and inhibits neurite outgrowth in primary cortical and hippocampal neurons: A quantitative analysis [J].
Evans, Nicholas A. ;
Facci, Laura ;
Owen, Davina E. ;
Soden, Peter E. ;
Burbidge, Stephen A. ;
Prinjha, Rab K. ;
Richardson, Jill C. ;
Skaper, Stephen D. .
JOURNAL OF NEUROSCIENCE METHODS, 2008, 175 (01) :96-103
[9]
ALZHEIMERS-DISEASE - INITIAL REPORT OF THE PURIFICATION AND CHARACTERIZATION OF A NOVEL CEREBROVASCULAR AMYLOID PROTEIN [J].
GLENNER, GG ;
WONG, CW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (03) :885-890
[10]
Animal models of Alzheimer's disease and frontotemporal dementia [J].
Gotz, Jurgen ;
Ittner, Lars M. .
NATURE REVIEWS NEUROSCIENCE, 2008, 9 (07) :532-544